Skip to main content
. 2024 May 15;18:1371–1377. doi: 10.2147/OPTH.S450220

Table 1.

Demographics and Baseline Glaucoma Data

Parameter Value
Subject-level (N=81)
Age (yr), mean (SD) 73.7 (11.5)
Sex, n (%)
 Male 20 (24.7)
 Female 61 (75.3)
Ethnicity, n (%)
 Caucasian 61 (75.3)
 Black 11 (13.6)
 Hispanic 4 (4.9)
 Other 5 (6.2)
Eye-level (N=129)
Glaucoma diagnosis, n (%)
 Primary open-angle 111 (86.0)
 Normal tension 9 (7.0)
 Other 9 (7.0)
Mean (SD) IOP, mmHg 16.0 (4.0)
No. of glaucoma medications at baseline, n (%)
 0 11 (8.5)
 1 53 (41.1)
 2 32 (24.8)
 3 26 (20.2)
 >3 7 (5.4)
Prior glaucoma procedures, n (%)
 Any 69 (53.5)
 Laser trabeculoplasty 41 (31.8)
 Laser iridotomy 8 (6.2)
 Goniotomy (excisional or by ablation) 12 (9.3)
 Trabecular micro-bypass implant or canal stent 10 (7.8)
 Cilioablation 11 (8.5)
 Tube-shunt 5 (3.9)
 Trabeculectomy 5 (3.9)
 Gel stent 7 (5.4)
 Gonioscopy-assisted transluminal trabeculotomy 7 (5.4)
Phakic status, n (%)
 Phakic 46 (35.7)
 Pseudophakic 83 (64.3)